References

Papers produced and published by the outcome measures group;

  • Davidson SE, Burns M, Routledge J, West CML, Swindell R, Logue JP, Wylie J, Slevin NJ, Cowan RA, Magee.B, Harris MA. Short report: A morbidity scoring scheme for clinical oncology practice: Questionnaires produced from the LENT SOMA scoring system. Clin.Oncol. 2002; 14:68-69.
  • Appel W, West CML, Davidson SE. Grand round: Late morbidity in a patient with carcinoma of the cervix. Clin. Oncol. 2002; 14:437-41.
  • Davidson SE. Assessment of treatment -related morbidity in gynaecological malignancy. Cancer Topics 2002; 11:16-18.
  • Livsey JE, Routledge J, Burns M, Swindell R, Davidson SE, Cowan RA, Logue JP, Wylie J. Scoring of treatment related late effects in prostate cancer. Radiother.Oncol. 2002; 65:109-121.
  • Routledge JA, Burns MP, Swindell R, Khoo VS, West CML, Davidson SE. Evaluation of the LENT SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int JRadiat.Oncol.Biol.Phys.2003; 56:502-510.
  • Davidson SE, Burns M, Routledge J, Swindell R.The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales. Radiother.Oncol. 2003; 68:241-7.
  • Wilkinson JM, Harris MA, Davidson SE, Welch RS, Hunter RD, Swindell R. A retrospective study of bladder morbidity in patients treated with intracavitary brachytherapy for cervix cancer. BJR 2003; 897-903.
  • Davidson SE, Burns MP, Routledge JA, Swindell R, Bentzen S, West CML. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian Glossary. Radiother.Oncol. 2003; 69:195-200.
  • Ataman OU, Barrett A, Davidson SE, et al. Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer a report of the REACT working group of ESTRO. Radiother.Oncol. 2004; 237-249.
  • Jain P, Hunter RD, Livsey JE, Coyle C, Kitchener HC, Swindell R, Davidson SE. Pattern of failure and long term morbidity in patients undergoing postoperative radiotherapy for cervical cancer. Int J Gynecol Cancer. 2006; 16(5):1839-45.
  • Davidson SE, Faithfull S. Late Radiotherapy Effects: Is bowel morbidity adequately documented or patients' needs managed appropriately? Editorial Clin Oncol. 2006; 18:419-20.
  • Burns M, Costello J, Ryan-Woolley B, Davidson SE, Assessment of impact of late treatment effects in cervical cancer: an explorational study of women's sexualityEur J Cancer Care 2007; 16(4):364-72.
  • Kelly K, Swindell R, Routledge J, Burns M, Logue J P, Wylie J P. Prediction of urinary symptoms after 125iodine prostate brachytherapy. Clinical Oncol. 2006; 18(4):326-32.
  • Davidson SE, Trotti A, Ataman OU, Seong J, Lau FN, daMotta NW, Jeremic B. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Bio Phys 2007 In press.
  • Davidson SE, Trotti A, Ataman OU, Seong J, Lau FN, daMotta NW, Jeremic B. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2007; 69:1218-21.
  • West CML, Davidson SE. Measurement for gastrointestinal symptoms in radiation oncology. Curr. Opinion in Supportive and Palliative Care 2009; 3:36-40.
  • Barker CL, Routledge JA, Farnell DJJ, Swindell R, Davidson SE. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. BJC 2009; 100(10):1558-65.
  • Ho K, Farnell DJJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, Davidson SE. Developing a CTCAE patient questionnaire for late toxicity after head and neck radiotherapy Eur J Cancer 2009; 45:1992-8.
  • Farnell DJJ, Routledge JA, Hannon R, Logue JP, Cowan RA, Wylie JP, Barraclough LH, Livsey JE, Swindell R, Davidson SE. Efficacy of Data Capture for Patient-Reported Toxicity Following Radiotherapy Treatment for Prostate or Cervical Cancer Eur J Cancer 2010; 46:534-540.
  • Ho K, Farnell DJJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, Davidson SE. Comparison of Patient-Reported Late Treatment Toxicity (LENT-SOMA) with Quality of Life (EORTC C30 and C35) assessment after Head and Neck Radiotherapy Radiother.Oncol. 2010; 97:270-5.
  • Farnell DJJ, Mandell P, Anandadas C, Routledge JA, Burns MP, Logue JP, Wylie JP, Swindell R, Livsey JE, West CML, Davidson SE. Development of a Patient-Reported Questionnaire for Collecting Toxicity Data following Prostate Brachytherapy Radiotherapy and Oncology. Radiother.Onocl. 2010; 97:136-142.
  • Anandadas CA, Clarke NW, Davidson SE, O'Reilly PH, Logue JP, Gilmore L, Swindell R, Brough RJ, Wemyss-Holden GD, Lau MW, Javle PM, Ramani VAC, Wylie JP, Collins GN, Brown S, Cowan RA. Early prostate cancer which treatment do men prefer and why? BJ Urol. 2011; 107:1762-8.
  • Henson CC, Andreyev HJ, Symonds RP, Peel D, Swindell R, Davidson SE. Late onset bowel dysfunction after pelvic radiotherapy: A national survey of current practice and opinions of clinical oncologists Clin Oncol (R Coll Radiol). 2011; 23:552-557.
  • Henson CC, Davidson SE. After the cure: gastrointestinal problems in cancer survivors Primary Care Women's Health Journal 2011; In press.
  • Anandadas CA, Davidson SE, Clarke NW, O'Reilly PH, Logue JP, Gilmore L, Swindell R, Brough RJ, Wemyss-Holden GD, Lau MW, Javle PM, Ramani VAC, Wylie JP, Collins GN, Brown S, Cowan RA. Quality of Life in men treated for early prostate cancer: A prospective patient preference cohort study. J.Cancer Therapy 2011; In press.
  • Henson C, Davidson SE, Lalji A, Symonds P, Swindell R, Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists. J Support.Care.Cancer. 2011; In press.
  • Andreyev J, Davidson S, Gillespie C, Allum W, Swarbrick E Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 2011; in press.
  • Barraclough LH, Routledge JA, FarnellDJ, BurnsMP, Swindell R, Livsey J, Davidson SE. Prospective analysis of patient-reported late toxicity following pelvic radiotherapy in patients with gynaecological cancer. Radiother.Oncol.2012; in press.
  • Joseph LA, Routledge JA, Burns MP, Swindell R, Sykes AJ, Slevin NJ, Davidson SE. The value of the Hospital Anxiety and Depression Scale in the follow-up of head and neck cancer patients. JLO 2012; in press.
;